Franklin Resources’s MBX Biosciences MBX Stock Holding History

Franklin Resources’s Portfolio MBX Stock Details MBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15.4M	Buy	293,217 +40,552	+16%	+$2.54M	﹤0.01%	1082
2026 Q2	$13.9M	Buy	+252,665	New	+$8.82M	﹤0.01%	1133
2025 Q4	–	Sell	-1,307,288	Closed	-$22.9M	–	3303
2025 Q3	$22.9M	Buy	1,307,288 +812,436	+164%	+$10.9M	0.01%	911
2025 Q2	$5.65M	Buy	494,852 +125,537	+34%	+$1.28M	﹤0.01%	1320
2025 Q1	$2.73M	Buy	369,315 +15	+0%	+$159	﹤0.01%	1584
2024 Q4	$6.81M	Sell	369,300 -80,700	-18%	-$1.72M	﹤0.01%	1241
2024 Q3	$10.6M	Buy	+450,000	New	+$10.3M	﹤0.01%	1108

Other funds holding MBX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

NVP Associates Menlo Park, California $282M AUM 85.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

Franklin Resources's MBX Position: Q3 2026 in Review

Franklin Resources increased its MBX Biosciences (MBX) stake by 16% in Q3 2026, buying an estimated $2.54M and bringing the position to 293,217 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

Franklin Resources first reported a position in MBX in Q3 2024 and has held it in 7 quarters since. The position peaked at $22.9M in Q3 2025. 130 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

Franklin Resources held 293,217 shares of MBX Biosciences worth $15.4M as of Q3 2026.
Franklin Resources bought 40,552 MBX Biosciences shares in Q3 2026, an estimated $2.54M.
MBX Biosciences made up ﹤0.01% of Franklin Resources's portfolio in Q3 2026, its #1082 holding.
Franklin Resources first reported a position in MBX Biosciences in Q3 2024 and has held it in 7 quarters since.
Franklin Resources's MBX Biosciences position peaked at $22.9M in Q3 2025.
130 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.